Skip to content

Prediction of Specific Time of Death for Terminal Malignant Tumor Patients

Prediction of Specific Time of Death for Terminal Malignant Tumor Patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091421
Enrollment
Unknown
Registered
2024-10-28
Start date
2023-09-07
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Terminal Malignant Tumor Patients

Interventions

Sponsors

Taizhou Tumor Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Pathologically confirmed diagnosis of malignant tumor; (2) Expected survival time of less than 12 months; (3)No standard anti-tumor treatment options available; (4) Complete clinical data, including age, sex, dietary intake, physical fitness, respiration, consciousness, systolic blood pressure, pulse, nutrition, organ condition, axillary temperature, urine output, edema, oxygen saturation, etc.; (5) Signed consent form for waiving invasive resuscitation measures such as cardiopulmonary resuscitation and endotracheal intubation; (6) Permitted treatments include: enteral and parenteral nutritional support, blood product transfusion, antibiotic infusion, and palliative treatments such as radiotherapy, chemotherapy, and surgery for symptom relief only (e.g., palliative radiotherapy for pain relief, intraperitoneal or intrapleural chemotherapy for effusions, colostomy, and central venous catheter placement).

Exclusion criteria

Exclusion criteria: (1) Systemic chemotherapy; (2) Radical radiotherapy.

Design outcomes

Primary

MeasureTime frame
Overall survival;C Statistic;

Secondary

MeasureTime frame
age;sex;dietary intake;physical fitness;respiration; consciousness;systolic blood pressure;pulse;nutrition;organ condition;axillary temperature;urine output;edema;oxygen saturation;

Countries

China

Contacts

Public ContactLin Zheng

Department of Radiation Oncology, Taizhou Tumor Hospital

y215180575@zju.edu.cn+86 152 5860 2261

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026